Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genmab
Biotech
Genmab buys 2nd antibody from Scancell in deal worth up to $630M
Scancell can earn up to $630 million from the new sale if Genmab spins the antibody into drug products across all defined modalities.
Darren Incorvaia
Dec 4, 2024 11:55am
Genmab open to more M&A if it makes 'strategic sense,’ CFO says
Nov 21, 2024 1:05pm
NJ biopharmas make pledge to give time off for clinical trials
Nov 20, 2024 10:00am
The JPM pregame: Jam-packed Jefferies conference makes its mark
Nov 19, 2024 11:00am
Genmab axes 3 programs to focus on plumped-up pivotal pipeline
Nov 7, 2024 5:41am
BioMarin builds exec team with biotech vets—Chutes & Ladders
Aug 23, 2024 8:30am
